Map of Pancreatica Walks and Runs

Category Archives: Pancreatic Cancer

Phase 2 Results of Gemcitabine and Monoclonal Antibody for Advanced Pancreatic Cancer

It’s hard to keep up with company changes in the biotech world, but a recent published study in the Annals of Oncology, the official journal of the European Society for Medical Oncology (ESMO) includes highly intriguing results of an unusual combination for advanced pancreatic cancer of gemcitabine and the fully human monoclonal antibody (Mab) AGS-1C4D4. […]

Share Button

MicroRNA plus CA19-9 as a Diagnostic Marker for Pancreatic Cancer?

The search for a screening or diagnostic marker in pancreatic cancer is paramount. If the disease could be found earlier, it is likely that serious inroads could be made into improved survival advantage for patients. Wang and associates at Fudan University in Shanghai, China published an intriguing article in April’s edition of the Journal of […]

Share Button

More Abraxane in Combination with Gemcitabine for Pancreatic Cancer

Two studies have been published on April 1, 2013 about the efficacy of the combination drug regimen of nab-Paclitaxel (Abraxane) plus gemcitabine.  These follow closely the earlier results of the international study of 861 patients with advanced pancreatic cancer who appeared to have gained survival advantage as presented by Dr. Daniel Von Hoff and colleagues […]

Share Button
Page 27 of 32« First...1020...2526272829...Last »